FDA approves durvalumab for resectable gastric or gastroesophageal junction adenocarcinoma

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-durvalumab-resectable-gastric-or-gastroesophageal-junction-adenocarcinoma?utm_medium=email&utm_source=govdelivery